NIH Funding Acknowledgment

Updated November 4, 2026, in accordance with NIH guidance

 

In order to comply with the NIH Public Access Policy, publications and other dissemination materials must acknowledge the Southern California Clinical and Translational Science Institute (SC CTSI) by citing the NIH grant number(s) if the following apply:

 

  • The research was supported, in whole or in part, by SC CTSI funding (e.g., Pilot Awards, KL2 support, salary support, or other SC CTSI-funded programs), or
  • The publication is co-authored by SC CTSI personnel acting in their CTSI role. 

     

In all other cases where SC CTSI supported published work, please acknowledge the institute by name, but do not cite the grant number. This type of support includes general consultations or use of shared resources or infrastructure (e.g., REDCap or cohort feasibility tools) that did not substantially contribute to the research.

If you are unsure whether your publications or other dissemination materials require SC CTSI acknowledgment, please contact Cathelin Huang at ei@sc-ctsi.org before submission.

How to Acknowledge SC CTSI

If authorship or funding was provided by SC CTSI, please 1) include the appropriate NIH funding acknowledgment using the applicable grant citation language (below) in the manuscript’s Funding or Acknowledgements section or the acknowledgements area of other dissemination materials. If the project was supported by more than one grant, please reference all relevant grant numbers. Then 2) submit to PubMed Central to receive a PMCID (Watch the video training).

General SC CTSI Support (UL1)

This work was supported by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health under award number UL1TR001855 to the Southern California Clinical and Translational Science Institute (SC CTSI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

For Mentored Career Development in Clinical Translational Science (MCD-CTS) Scholars (NIH-funded KL2 and institutionally funded):

NIH-Funded MCD-CTS Scholars (KL2)

This work was supported by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health under award number KL2TR001854 (for salary, fringe, research supplies, and administrative/co-curricular activities) and UL1TR001855 (for administrative/co-curricular activities) to the Southern California Clinical and Translational Science Institute (SC CTSI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Institutionally Funded MCD-CTS Scholars

This work was supported by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health under award number KL2TR001854 and UL1TR001855 (for administrative/co-curricular activities) to the Southern California Clinical and Translational Science Institute (SC CTSI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

NIH Public Access Policy

All publications citing SC CTSI grant numbers must comply with the NIH Public Access Policy.

The NIH Public Access Policy requires authors to submit final peer-reviewed journal manuscripts arising from NIH-funded research to PubMed Central immediately upon acceptance for publication. These manuscripts must be made publicly available in PubMed Central without embargo.